InsidersTradesSigma
Explore the full record of transactions filed by Dahlbeck Scott, Directeur Médical. Insider active across 1 company, notably Kiromic Biopharma, Inc.. Cumulatively, 1 filings have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Scott Dahlbeck is the Chief Medical Officer at Kiromic Biopharma, Inc. He is responsible for the company's medical strategy and oversees research and development initiatives.